EZH2 and urinary bladder cancer: In order to test the role of EZH2 in bladder cancer cells, we knocked down EZH2 by small interfering RNA and found its depletion reduced cell proliferation by 33.9% and 27.9%, 72 h after siRNA transfection (Figure 2C and 2D).